Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Replaces Previous $5B Credit Facility with New $2.5B Facility

NEW YORK – In documents filed with the US Securities and Exchange Commission on Wednesday, Danaher disclosed it entered into a new $2.5 billion 364-day revolving credit facility with Bank of America as administrative agent on June 5.

The new facility, which expires on June 5, 2021, replaces Danaher's existing $5 billion revolving credit facility, which it entered into on August 27 2019. There were no outstanding amounts under the 2019 facility when it was replaced.

Under the facility, Danaher can convert any outstanding loans when the new credit facility expires into term loans due one year after the scheduled termination date after paying a .75 percent fee. 

In the SEC documents, Washington, DC-based Danaher said it intends to use the credit facility for liquidity support for the firm's US and European commercial paper programs and for general corporate purposes.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.